Pediatric Asthma Plus Atopic Dermatitis Associated With Poor Sleep Outcomes
Asthma plus atopic dermatitis may lead to poorer sleep-specific outcomes in pediatric patients.
Asthma plus atopic dermatitis may lead to poorer sleep-specific outcomes in pediatric patients.
Among patients with severe asthma, benralizumab treatment improved nasal symptoms, which worsen with increasing baseline blood eosinophil count.
In a real-world setting, mepolizumab therapy significantly reduced the rate of asthma exacerbations and their related costs.
Children with a family history of cancer may be more likely to develop childhood asthma.
Mepolizumab reduced the number of exacerbations in patients with severe asthma, but exacerbations per month remained relatively stable throughout the year without a clear seasonal influence.
Patients with tobacco dependence and pulmonary embolism are likely to be readmitted to the hospital within 30 days of initial discharge due to pulmonary embolism.
Gefapixant has demonstrated efficacy in improving objective cough frequency and quality of life among individuals with chronic cough.
Patients with acute exacerbation of COPD and acute MI who received invasive ventilation with high-concentration oxygen therapy experienced significant improvements in outcomes compared with patients on moderate-concentration oxygen therapy.